# | Title | Journal | Year | Citations |
---|
1 | Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial | Lancet, The | 2017 | 3,872 |
2 | Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment | Journal of the American Medical Directors Association | 2020 | 2,796 |
3 | Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial | Lancet, The | 2017 | 1,749 |
4 | Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma | JAMA - Journal of the American Medical Association | 2017 | 1,619 |
5 | A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants | Nature Genetics | 2016 | 1,167 |
6 | Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program | Nature | 2021 | 1,069 |
7 | Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial | Lancet Oncology, The | 2010 | 852 |
8 | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial | Lancet Oncology, The | 2014 | 849 |
9 | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial | Lancet Oncology, The | 2014 | 800 |
10 | Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos) | Journal of Hepato-Biliary-Pancreatic Sciences | 2018 | 723 |
11 | Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial | Lancet Oncology, The | 2014 | 713 |
12 | Therapeutic siRNA silencing in inflammatory monocytes in mice | Nature Biotechnology | 2011 | 697 |
13 | Morbidity and Mortality of Laparoscopic Gastrectomy Versus Open Gastrectomy for Gastric Cancer | Annals of Surgery | 2010 | 684 |
14 | Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea | International Journal of Epidemiology | 2017 | 674 |
15 | COVID-19 and diabetes mellitus: from pathophysiology to clinical management | Nature Reviews Endocrinology | 2021 | 653 |
16 | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer | JAMA Oncology | 2020 | 611 |
17 | A pathogenic picornavirus acquires an envelope by hijacking cellular membranes | Nature | 2013 | 597 |
18 | PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project | Journal of Thoracic Oncology | 2018 | 589 |
19 | Bioactive calcium phosphate materials and applications in bone regeneration | Biomaterials Research | 2019 | 556 |
20 | Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis | BMC Medicine | 2016 | 534 |
21 | Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study | Lancet Oncology, The | 2016 | 533 |
22 | Increasing Prevalence of Metabolic Syndrome in Korea | Diabetes Care | 2011 | 527 |
23 | Brain charts for the human lifespan | Nature | 2022 | 518 |
24 | Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea | Korean Journal of Radiology | 2020 | 496 |
25 | Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial | Lancet Oncology, The | 2018 | 491 |
26 | Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis | Journal of Hepato-Biliary-Pancreatic Sciences | 2018 | 470 |
27 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer | Gastric Cancer | 2015 | 415 |
28 | A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results | Surgical Endoscopy and Other Interventional Techniques | 2005 | 403 |
29 | Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos) | Journal of Hepato-Biliary-Pancreatic Sciences | 2018 | 387 |
30 | Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 | Annals of Oncology | 2018 | 387 |
31 | The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects | Korean Journal of Pediatrics | 2018 | 374 |
32 | Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases | European Respiratory Review | 2018 | 370 |
33 | Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study | Lancet Oncology, The | 2018 | 370 |
34 | 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology | Korean Journal of Radiology | 2018 | 370 |
35 | The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer | Cancer | 2012 | 368 |
36 | Bilateral vestibulopathy: Diagnostic criteria Consensus document of the Classification Committee of the Bárány Society1 | Journal of Vestibular Research: Equilibrium and Orientation | 2017 | 364 |
37 | Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project | Gastric Cancer | 2017 | 357 |
38 | Psychiatric Comorbidity Assessed in Korean Children and Adolescents Who Screen Positive for Internet Addiction | Journal of Clinical Psychiatry | 2006 | 347 |
39 | Determination of Brain Death/Death by Neurologic Criteria | JAMA - Journal of the American Medical Association | 2020 | 346 |
40 | Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project | Clinical Cancer Research | 2017 | 342 |
41 | Criterion validity of the Pittsburgh Sleep Quality Index: Investigation in a non-clinical sample | Sleep and Biological Rhythms | 2006 | 339 |
42 | Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer | JAMA Oncology | 2019 | 339 |
43 | Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial | Lancet Oncology, The | 2014 | 336 |
44 | Effects of Statins on Coronary Atherosclerotic Plaques | JACC: Cardiovascular Imaging | 2018 | 335 |
45 | Molecular Mechanisms of Dermal Aging and Antiaging Approaches | International Journal of Molecular Sciences | 2019 | 332 |
46 | The Association of Newly Identified Respiratory Viruses with Lower Respiratory Tract Infections in Korean Children, 2000–2005 | Clinical Infectious Diseases | 2006 | 327 |
47 | A Practical MRI Grading System for Lumbar Foraminal Stenosis | American Journal of Roentgenology | 2010 | 325 |
48 | Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT) | Annals of Surgery | 2019 | 322 |
49 | Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study | Journal of Clinical Oncology | 2021 | 320 |
50 | Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133) | Journal of Clinical Oncology | 2021 | 317 |